docetaxel anhydrous has been researched along with saikosaponin d in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (saikosaponin d) | Trials (saikosaponin d) | Recent Studies (post-2010) (saikosaponin d) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 437 | 1 | 265 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Dong, Q; Feng, J; Jiang, X; Li, Y; Liu, M; Nik Nabil, WN; Song, Z; Xi, Z; Xu, H; Zhou, H | 1 |
1 other study(ies) available for docetaxel anhydrous and saikosaponin d
| Article | Year |
|---|---|
Saikosaponin A enhances Docetaxel efficacy by selectively inducing death of dormant prostate cancer cells through excessive autophagy.
Topics: Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Docetaxel; Humans; Male; Neoplasm Recurrence, Local; Prostate; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt | 2023 |